GlaxoSmithKline sets up $50 mln life sciences fund in Canada

GlaxoSmithKline sets up $50 mln life sciences fund in Canada

November 11th, 2011 // 1:50 pm @

Pharmaceutical major GlaxoSmithKline is setting up a $50 million fund in Canada to invest in early stage research.

The GSK Canada Life Sciences Innovation fund will be managed by GSK in Canada and the company’s venture capital division, SR One.

“The GSK Canada Life Sciences Innovation Fund will provide a competitive advantage to Canada’s life sciences industry and help advance the commercialization of research,” said Paul Lucas, chief executive of GSK.


Subscribe Now

Testimonial

"ExpertBriefings.com always selects excellent speakers – some of the best I have ever heard. Their messages are direct, clear, timely, and relevant."

Anon A. Mouse

Featured Partner